Overview
Norsa Pharma is a Polish manufacturer that offers a wide range of specialized dietary supplements tailored to various health needs. Their product lineup includes items such as Omegasense Gold, Creatine Nucleo, and Vitamin D3+K2, among others. The company focuses on nutritional preparations to support health and well-being.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-02-13. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
8 public aid cases recorded, with a total value of $708,549.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,596 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,670 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,670 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-07-01 | Kompleksowe opcje terapii niedoborów z˙ywieniowych w mukowiscydozie: biodoste?pnos´c´, skutecznos´c´, redukcja kosztów. | $449,843 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board together with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mateusz Łukasz Data (43) | 33 | $891.41 | 44% |
Marta Kowal (43) | 17 | $459.21 | 22.6667% |
| 12 | $324.15 | 16% | |
Jarosław Mirosław Walkowiak (59) | 8 | $216.10 | 10.6667% |
Others | 5 | $135.06 | 6.6666% |
Beneficial owners
| Person | Rights |
|---|---|
Mateusz Łukasz Data (43)  | Shareholder of a limited liability company, 3300.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | |
| Master PharmS.A. | $23,116,954.19 | masterpharm.pl | |
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | |
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | |
| Premium Rosasp. z o.o. | $10,653,161.35 | premiumrosa.eu | |
| Yangosp. z o.o. | $8,214,312.60 | yango.pl | |
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | |
| Chias Brothers Europesp. z o.o. | $4,935,357.96 | chias.eu | |
| Noble Healthsp. z o.o. | $4,558,481.50 | noblehealth.com | |
| OnesanoS.A. | $3,063,535.91 | onesano.pl |
Change history
| Date | Event |
|---|---|
| 2025-06-20 | PKD change (Removed: 10.89.Z, 70.22.Z, 72.11.Z, 72.19.Z, 73.20.Z, 74.90.Z; Added: 10.89.A, 72.10.Z, 74.99.Z) |
| 2020-02-20 | Share capital change (6,900.00 PLN → 7,500.00 PLN) |
| 2019-11-27 | Share capital change (6,300.00 PLN → 6,900.00 PLN) |
| 2018-06-11 | Address change (Ul. Czerwone Maki 84, 32-392, Kraków → Ul. Prof. Michała Życzkowskiego 14, 31-864, Kraków) |
| 2018-06-11 | Share capital change (5,000.00 PLN → 6,300.00 PLN) |
FAQ
Last updated: 2026-05-19